3737 - Zhongzhi Pharmaceutical Holdings News Story
HK$1.4 0.0 0.0%
Last Trade - 7:01am
| Market Cap | £108.3m |
| Enterprise Value | £96.8m |
| Revenue | £176.2m |
| Position in Universe | 3155th / 6091 |
BRIEF-Zhongzhi Pharmaceutical Posts HY Profit Attributable Of RMB47 Mln
Wed 29th August, 2018 4:03pm
Aug 29 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
3737.HK :
* HY REVENUE RMB556.7 MILLION VERSUS RMB431.5 MILLION
* HY PROFIT ATTRIBUTABLE RMB47 MILLION VERSUS RMB38.5
MILLION
* RECOMMENDS INTERIM DIVIDEND OF HK2.65 CENTS PER SHARE & A
SPECIAL DIVIDEND OF HK1.70 CENTS PER SHARE
Source text for Eikon: ID:nHKS9Z1L6g
Further company coverage: 3737.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zhongzhi Pharmaceutical Holdings
See all news
